Cargando…
Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer
Locally advanced rectal cancer is typically treated with chemoradiotherapy followed by surgery. Most patients do not display a complete response to chemoradiotherapy, but resistance mechanisms are poorly understood. ST6GAL-1 is a sialyltransferase that adds the negatively charged sugar, sialic acid...
Autores principales: | Smithson, Mary, Irwin, Regina, Williams, Gregory, Alexander, Katie L., Smythies, Lesley E., Nearing, Marie, McLeod, M. Chandler, Al Diffalha, Sameer, Bellis, Susan L., Hardiman, Karin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857646/ https://www.ncbi.nlm.nih.gov/pubmed/35041825 http://dx.doi.org/10.1016/j.jbc.2022.101594 |
Ejemplares similares
-
Regulation of inflammatory signaling by the ST6Gal-I sialyltransferase
por: Holdbrooks, Andrew T., et al.
Publicado: (2020) -
ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression
por: Bhalerao, Nikita, et al.
Publicado: (2023) -
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
por: Schultz, Matthew J, et al.
Publicado: (2013) -
Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli
por: Ortiz-Soto, Maria Elena, et al.
Publicado: (2016) -
Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death
por: Britain, Colleen M., et al.
Publicado: (2018)